MDKA Stock Overview
Engages in the wholesale and retail distribution of pharmaceutical products in the Republic of Croatia. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Medika d.d. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €5,700.00 |
| 52 Week High | €7,700.00 |
| 52 Week Low | €5,550.00 |
| Beta | 0.057 |
| 11 Month Change | 0.89% |
| 3 Month Change | -5.00% |
| 1 Year Change | -18.57% |
| 33 Year Change | 47.85% |
| 5 Year Change | 160.10% |
| Change since IPO | 433.24% |
Recent News & Updates
Shareholder Returns
| MDKA | HR Healthcare | HR Market | |
|---|---|---|---|
| 7D | -3.4% | -1.0% | 1.5% |
| 1Y | -18.6% | 5.3% | 26.0% |
Return vs Industry: MDKA underperformed the HR Healthcare industry which returned 7.2% over the past year.
Return vs Market: MDKA underperformed the HR Market which returned 26% over the past year.
Price Volatility
| MDKA volatility | |
|---|---|
| MDKA Average Weekly Movement | 4.7% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in HR Market | 6.3% |
| 10% least volatile stocks in HR Market | 1.8% |
Stable Share Price: MDKA has not had significant price volatility in the past 3 months compared to the HR market.
Volatility Over Time: Insufficient data to determine MDKA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1922 | 1,018 | Jasminko Herceg | www.medika.hr |
Medika d.d., together with its subsidiaries, engages in the wholesale and retail distribution of pharmaceutical products in the Republic of Croatia. The company primarily sells, stores, and distributes human and veterinary drugs, and equipment and dental supplies, as well as dietetic, cosmetic, hygienic, medicinal, and other products. It serves pharmacies, healthcare institutions, hospitals, health centers, outpatient facilities, doctor’s offices, wholesalers, and specialized stores; and dental practices, veterinary clinics, and medical centers, as well as herbal pharmacies, companies, optics, and others.
Medika d.d. Fundamentals Summary
| MDKA fundamental statistics | |
|---|---|
| Market cap | €165.04m |
| Earnings (TTM) | €20.23m |
| Revenue (TTM) | €811.07m |
8.2x
P/E Ratio0.2x
P/S RatioIs MDKA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDKA income statement (TTM) | |
|---|---|
| Revenue | €811.07m |
| Cost of Revenue | €746.12m |
| Gross Profit | €64.96m |
| Other Expenses | €44.72m |
| Earnings | €20.23m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 698.83 |
| Gross Margin | 8.01% |
| Net Profit Margin | 2.49% |
| Debt/Equity Ratio | 47.2% |
How did MDKA perform over the long term?
See historical performance and comparison